- FDA Approves Keytruda (pembrolizumab) for the Treatment of Patients with Hepatocellular Carcinoma (HCC) Who Have Been Previously Treated with Sorafenib
- Do You Have News to Share? Get It Published.
- European markets close mildly lower as sterling stabilizes after Brexit drama
- AstraZeneca phase III MYSTIC trial of Imfinzi and tremelimumab in stage IV NSCLC fails to meet primary endpoint
- Benefits of quitting tobacco
Join us in the battle against lung cancer!
For more information, seeget involved!